Abstract
Over the past decade, a great effort has been made by the chemical community to improve the efficiency of organic transformations and allow sustainable processes. Merging the use of supported and recyclable organocatalysts and aqueous conditions for the asymmetric synthesis of valuable molecules, has led to outstanding contributions in the area of green chemistry. Recent progresses in the field include the implementation of these methodologies in the large scale production of chiral molecules using automated flow chemistry.
Keywords: Aqueous, dendrimers, enantioselective, flow chemistry, immobilization, ionic liquids, organocatalysis, polymers.
Graphical Abstract
Current Organocatalysis
Title:Pursuing Chemical Efficiency by Using Supported Organocatalysts for Asymmetric Reactions under Aqueous Conditions
Volume: 2 Issue: 2
Author(s): Gabriela Guillena, Diego Alonso, Alejandro Baeza, Rafael Chinchilla, Jesus Flores-Ferrandiz, Melania Gomez-Martinez and Paz Trillo
Affiliation:
Keywords: Aqueous, dendrimers, enantioselective, flow chemistry, immobilization, ionic liquids, organocatalysis, polymers.
Abstract: Over the past decade, a great effort has been made by the chemical community to improve the efficiency of organic transformations and allow sustainable processes. Merging the use of supported and recyclable organocatalysts and aqueous conditions for the asymmetric synthesis of valuable molecules, has led to outstanding contributions in the area of green chemistry. Recent progresses in the field include the implementation of these methodologies in the large scale production of chiral molecules using automated flow chemistry.
Export Options
About this article
Cite this article as:
Guillena Gabriela, Alonso Diego, Baeza Alejandro, Chinchilla Rafael, Flores-Ferrandiz Jesus, Gomez-Martinez Melania and Trillo Paz, Pursuing Chemical Efficiency by Using Supported Organocatalysts for Asymmetric Reactions under Aqueous Conditions, Current Organocatalysis 2015; 2 (2) . https://dx.doi.org/10.2174/2213337202666150428233534
DOI https://dx.doi.org/10.2174/2213337202666150428233534 |
Print ISSN 2213-3372 |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-3380 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Amyloid-Beta Peptide 1-42 Causes Microtubule Deregulation through N-methyl-D-aspartate Receptors in Mature Hippocampal Cultures
Current Alzheimer Research Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection
Current Topics in Medicinal Chemistry Type A and B Monoamine Oxidase in Age-Related Neurodegenerative Disorders: Their Distinct Roles in Neuronal Death and Survival
Current Topics in Medicinal Chemistry Amyloid Beta Peptide, 4-Hydroxynonenal and Apoptosis
Current Alzheimer Research Interferon gama induced Tryptophan Degradation Neuropsychiatric and Immunological Consequences
Current Drug Metabolism Tea and Health: Studies in Humans
Current Pharmaceutical Design Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases
Current Drug Metabolism Clearing the Brains Cobwebs: The Role of Autophagy in Neuroprotection
Current Neuropharmacology Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis
Current Drug Metabolism Conformational Changes and Aggregation of Expanded Polyglutamine Proteins as Therapeutic Targets of the Polyglutamine Diseases: Exposed β-Sheet Hypothesis
Current Pharmaceutical Design Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms
Current Neuropharmacology Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Conformations and Biological Activities of Amyloid Beta Peptide 25-35
Current Protein & Peptide Science Serotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Current Drug Targets Untapped Potential of Disordered Proteins in Current Druggable Human Proteome
Current Drug Targets Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis
Current Pharmaceutical Biotechnology Pharmacological Modulation of the State of Awareness in Patients with Disorders of Consciousness: An Overview
Current Pharmaceutical Design DNAJ Proteins and Protein Aggregation Diseases
Current Topics in Medicinal Chemistry Predementia and Dementia Syndromes: Possible Role of Lipoprotein Metabolism
Vascular Disease Prevention (Discontinued) α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease
Current Drug Targets